**Question:** Which antineoplastic drug is a peptide?

**Core Concept:** Antineoplastic drugs are substances that inhibit or prevent the growth of cancer cells, either by causing cell cycle arrest or inducing cell death. Peptides are molecules made up of amino acids joined together by peptide bonds.

**Why the Correct Answer is Right:** Thalidomide (Option D) is a peptide drug derived from a synthetic analogue of the naturally occurring amino acid, glutamic acid. It acts as an immunomodulator and anti-angiogenic agent, which helps in reducing tumor growth and progression.

**Why Each Wrong Option is Incorrect:**

A. Chemotherapeutic agents like cyclophosphamide (a nitrogen mustard) and vincristine (a vinca alkaloid) are not peptides. Cyclophosphamide is an alkylating agent, and vincristine is a microtubule inhibitor.

B. Immunosuppressive agents like cyclosporine and tacrolimus (Option A) are not peptides. Cyclosporine is a cyclic undecapeptide, while tacrolimus is an immunosuppressive macrolide antibiotic.

C. Melphalan (Option B) is a nitrogen mustard alkylating agent rather than a peptide.

**Clinical Pearl / High-Yield Fact:** Peptide hormones, such as insulin and glucagon, play essential roles in regulating glucose homeostasis, hormone secretion, and other physiological processes. Understanding the properties and actions of peptides in medicine is crucial for practicing physicians, especially when considering the use, side effects, and interactions of peptide-based drugs like thyrotropin-releasing hormone (TRH), somatostatin, and glucagon-like peptide-1 (GLP-1).

**Correct Answer:** Thalidomide (Option D) is a peptide drug.

Thalidomide was initially developed as a sedative in the 1950s but caused severe birth defects when prescribed to pregnant women in the 1960s. Since then, its use has been restricted, and it is now primarily used as an anti-inflammatory, immunomodulatory, and anti-angiogenic agent in the treatment of multiple myeloma, graft-versus-host disease (GVHD), and some autoimmune diseases.